UBS Group’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-6,474
Closed -$12K 8381
2017
Q1
$12K Buy
6,474
+4,791
+285% +$26.9K ﹤0.01% 6532
2016
Q4
$13K Buy
1,683
+425
+34% +$7.82K ﹤0.01% 6790
2016
Q3
$54K Buy
1,258
+789
+168% +$35.6K ﹤0.01% 5462
2016
Q2
$25K Buy
469
+31
+7% +$1.86K ﹤0.01% 6134
2016
Q1
$25K Sell
438
-1,271
-74% -$65.7K ﹤0.01% 6051
2015
Q4
$93K Buy
1,709
+1,404
+460% +$89.6K ﹤0.01% 5278
2015
Q3
$24K Hold
305
﹤0.01% 6557
2015
Q2
$29K Buy
305
+5
+2% +$344 ﹤0.01% 6524
2015
Q1
$15K Sell
300
-290
-49% -$11.5K ﹤0.01% 7314
2014
Q4
$22K Buy
+590
New +$18.6K ﹤0.01% 7557

Other funds holding ADPT

UBS Group's ADPT Position: Q2 2017 in Review

UBS Group sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 6,474 shares — an estimated $12K sold.

UBS Group first reported a position in ADPT in Q4 2014 and held it in 10 quarters. The position peaked at $93K in Q4 2015. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • UBS Group reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 6,474 Adeptus Health Inc shares in Q2 2017, an estimated $12K.
  • UBS Group first reported a position in Adeptus Health Inc in Q4 2014 and held it in 10 quarters.
  • UBS Group's Adeptus Health Inc position peaked at $93K in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.